John E. Kerrigan

Topoisomerase IIβ–Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by Dexrazoxane

Yi Lisa Lyu, John E. Kerrigan, Chao‐Po Lin et al. · Cancer Research · 2007 · 610 citations

Medicine, Oncology, Pharmacology +17

Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction

Longqin Hu, Sadagopan Magesh, Lin Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 200 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +14

Coupling of Drug Protonation to the Specific Binding of Aminoglycosides to the A Site of 16S rRNA: Elucidation of the Number of Drug Amino Groups Involved and their Identities

Malvika Kaul, Christopher M. Barbieri, John E. Kerrigan et al. · Journal of Molecular Biology · 2003 · 119 citations

Life Sciences, Biochemistry, Molecular Biology +9

Functional annotation of rare gene aberration drivers of pancreatic cancer

Yiu Huen Tsang, Turgut Dogruluk, Philip M. Tedeschi et al. · Nature Communications · 2016 · 88 citations · Full text

Medicine, Molecular Biology, Oncology +17

Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug Development

Philip M. Tedeschi, Alexei Vázquez, John E. Kerrigan et al. · Molecular Cancer Research · 2015 · 81 citations · Full text

Life Sciences, Biochemistry, Oncology +15